← Leaderboards
Jose M Teixeira
Massachusetts General Hospital
$9,923,155
Attributed
$9,923,155
Total exposure
9
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1M · FY2008–25$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,923,155 · 9
By mechanism
R01$7,772,040 · 4
R21$1,778,175 · 4
R29$372,940 · 1
Top collaborators
No co-investigators on record.
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Paul B Yu$13,557,400
- Patricia K Donahoe$22,937,861
- Shyamala Maheswaran$4,911,288
Others in their field
Top investigators on “Uterine Fibroids”
- Evan R. Myers · Duke University$19,951,646
- Walter C. Willett · Harvard University (Sch Of Public Hlth)$10,055,704
- Ayman Al-Hendy · University Of Texas Medical Br Galveston$9,015,762
- Serdar E Bulun · Northwestern University$8,654,579
- Lauren A Wise · Boston University Medical Campus$8,308,083
- Digna R Velez Edwards · Vanderbilt University$7,253,112
Research focus
Uterine FibroidsCellsUterusEtiologyGenesMyometrialHysterectomyWomanTissuesPathway InteractionsMyometriumGene ExpressionLeiomyomaBenignFibroid TumorSourceLeadReproductiveAffectBaseMolecularCharacteristicsComplexAfrican American
Grant awards (33)
Developing a baboon model for uterine fibroids$196,250
R21 · FY2025 · HD · contact PI
Developing a baboon model for uterine fibroids$235,500
R21 · FY2024 · HD · contact PI
Patient-specific targeting of uterine fibroids$406,256
R01 · FY2023 · HD · contact PI
Patient-specific targeting of uterine fibroids$431,991
R01 · FY2022 · HD · contact PI
Patient-specific targeting of uterine fibroids$520,799
R01 · FY2021 · HD · contact PI
Stem cell epigenetics in uterine fibroids$205,542
R21 · FY2021 · HD · contact PI
Myometrial stem cells$195,625
R21 · FY2021 · HD · contact PI
Patient-specific targeting of uterine fibroids$527,475
R01 · FY2020 · HD · contact PI
Stem cell epigenetics in uterine fibroids$258,792
R21 · FY2020 · HD · contact PI
Myometrial stem cells$234,750
R21 · FY2020 · HD · contact PI
Patient-specific targeting of uterine fibroids$554,975
R01 · FY2019 · HD · contact PI
Uterine Leiomyoma Development in Mouse Models$353,412
R01 · FY2017 · HD · contact PI
Endocrine disruption of myometrial stem cell activities$372,150
R01 · FY2016 · OD · contact PI
Uterine Leiomyoma Development in Mouse Models$356,124
R01 · FY2016 · HD · contact PI
Endocrine disruption of myometrial stem cell activities$364,707
R01 · FY2015 · OD · contact PI
Uterine Leiomyoma Development in Mouse Models$362,937
R01 · FY2015 · HD · contact PI
Endocrine disruption of myometrial stem cell activities$379,787
R01 · FY2014 · OD · contact PI
Uterine Leiomyoma Development in Mouse Models$367,492
R01 · FY2014 · HD · contact PI
Uterine Leiomyoma Development in Mouse Models$383,750
R01 · FY2013 · HD · contact PI
Endocrine disruption of myometrial stem cell activities$380,489
R01 · FY2013 · OD · contact PI
Endocrine disruption of myometrial stem cell activities$436,812
R01 · FY2012 · OD · contact PI
Beta-catenin biology in regeneration of uterine smooth muscle$303,971
R01 · FY2012 · HD · contact PI
Uterine-specific genetic modification and lymphangioleiomyomatosis$204,536
R21 · FY2012 · HL · contact PI
Beta-catenin biology in regeneration of uterine smooth muscle$304,179
R01 · FY2011 · HD · contact PI
Uterine-specific genetic modification and lymphangioleiomyomatosis$247,180
R21 · FY2011 · HL · contact PI
Beta-catenin biology in regeneration of uterine smooth muscle$313,897
R01 · FY2010 · HD · contact PI
Beta-catenin biology in regeneration of uterine smooth muscle$9,558
R01 · FY2010 · HD · contact PI
Beta-catenin biology in regeneration of uterine smooth muscle$316,870
R01 · FY2009 · HD · contact PI
Beta-catenin biology in regeneration of uterine smooth muscle$9,515
R01 · FY2009 · HD · contact PI
Beta-catenin biology in regeneration of uterine smooth muscle$314,894
R01 · FY2008 · HD · contact PI
REGULATION OF MIS TYPE II RECEPTOR AND TARGET GENES$119,700
R29 · FY2002 · CA
REGULATION OF MIS TYPE II RECEPTOR AND TARGET GENES$133,540
R29 · FY2001 · CA
REGULATION OF MIS TYPE II RECEPTOR AND TARGET GENES$119,700
R29 · FY2000 · CA